Pang J - Search Results

1

PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.

Wu Y, Yao X, Zhu M, Qian H, Jiang L, Lan T, Wu M, Pang J, Chen Y. Wu Y, et al. Among authors: pang j. Oncotarget. 2016 Jun 7;7(23):34190-200. doi: 10.18632/oncotarget.9074. Oncotarget. 2016. PMID: 27147579 Free PMC article.

2

Cross-linked hyaluronic acid gel inhibits metastasis and growth of gastric and hepatic cancer cells: in vitro and in vivo studies.

Lan T, Pang J, Wu Y, Zhu M, Yao X, Wu M, Qian H, Zhang Z, Gao J, Chen Y. Lan T, et al. Among authors: pang j. Oncotarget. 2016 Oct 4;7(40):65418-65428. doi: 10.18632/oncotarget.11739. Oncotarget. 2016. PMID: 27589842 Free PMC article.

3

Type II cGMP‑dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells.

Wu M, Wu Y, Qian H, Tao Y, Pang J, Wang Y, Chen Y. Wu M, et al. Among authors: pang j. Mol Med Rep. 2017 Oct;16(4):5729-5737. doi: 10.3892/mmr.2017.7290. Epub 2017 Aug 18. Mol Med Rep. 2017. PMID: 28849123

4

PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines.

Qian H, Tao Y, Jiang L, Wang Y, Lan T, Wu M, Pang J, Appiah-Kubi K, Chen Y, Wu Y. Qian H, et al. Among authors: pang j. Cell Biol Int. 2018 Apr;42(4):435-442. doi: 10.1002/cbin.10912. Epub 2017 Dec 14. Cell Biol Int. 2018. PMID: 29150923

5

Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?

Wu Y, Liu Y, Cai Z, Qin H, Li H, Su W, Wang Y, Qian H, Jiang L, Wu M, Pang J, Chen Y. Wu Y, et al. Among authors: pang j. Med Sci Monit. 2018 Feb 5;24:736-742. doi: 10.12659/msm.906213. Med Sci Monit. 2018. PMID: 29401205 Free PMC article.

6

The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades.

Wu Y, Yuan M, Su W, Zhu M, Yao X, Wang Y, Qian H, Jiang L, Tao Y, Wu M, Pang J, Chen Y. Wu Y, et al. Among authors: pang j. Ther Adv Med Oncol. 2018 Feb 1;10:1758834017751635. doi: 10.1177/1758834017751635. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29434677 Free PMC article.

7

Cross-linked hyaluronan gel inhibits the growth and metastasis of ovarian carcinoma.

Pang J, Jiang P, Wang Y, Jiang L, Qian H, Tao Y, Shi R, Gao J, Chen Y, Wu Y. Pang J, et al. J Ovarian Res. 2018 Mar 6;11(1):22. doi: 10.1186/s13048-018-0394-z. J Ovarian Res. 2018. PMID: 29510732 Free PMC article.

8

PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.

Wang Y, Appiah-Kubi K, Lan T, Wu M, Pang J, Qian H, Tao Y, Jiang L, Wu Y, Chen Y. Wang Y, et al. Among authors: pang j. Cell Biol Int. 2018 Sep;42(10):1358-1369. doi: 10.1002/cbin.11020. Epub 2018 Jul 4. Cell Biol Int. 2018. PMID: 29935031

9

Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways.

Wu Y, Cai Q, Li W, Cai Z, Liu Y, Li H, Pang J, Chen Y. Wu Y, et al. Among authors: pang j. Biosci Rep. 2019 Aug 13;39(8):BSR20190405. doi: 10.1042/BSR20190405. Print 2019 Aug 30. Biosci Rep. 2019. PMID: 31350342 Free PMC article.

10

Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation.

Lan T, Pang J, Wang Z, Wang Y, Qian H, Chen Y, Wu Y. Lan T, et al. Among authors: pang j. Biochem Biophys Res Commun. 2019 Oct 8;518(1):14-18. doi: 10.1016/j.bbrc.2019.07.126. Epub 2019 Aug 6. Biochem Biophys Res Commun. 2019. PMID: 31395339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,025 results

Search Page

Filters